Zosano Pharma Corporation (ZSAN)

NASDAQ: ZSAN · IEX Real-Time Price · USD
0.509 -0.021 (-3.98%)
Jan 18, 2022 11:06 AM EST - Market open

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019201820172016201520142013
Revenue
0.2200000.312.864.25
Revenue Growth
------89.06%-32.68%-
Cost of Revenue
0.17000000.10
Gross Profit
0.0500000.312.764.25
Selling, General & Admin
11.1911.819.368.188.186.324.424.58
Research & Development
21.6225.3925.5120.1220.4620.3710.957.64
Other Operating Expenses
000.510.070000
Operating Expenses
32.8137.235.3828.3728.6326.6815.3712.22
Operating Income
-32.76-37.2-35.38-28.37-28.63-26.37-12.61-7.97
Interest Expense / Income
0.720.520.380.821.191.561.850.76
Other Expense / Income
-0.11-0.13-0.4-0.080.010.5-0.22-3.12
Pretax Income
-33.37-37.59-35.36-29.11-29.83-28.43-14.24-5.61
Net Income
-33.37-37.59-35.36-29.11-29.83-28.43-14.24-5.61
Net Income Common
-33.37-37.59-35.36-29.11-29.83-28.43-14.24-5.61
Shares Outstanding (Basic)
6816921100
Shares Outstanding (Diluted)
6816921100
Shares Change
314.47%73.33%446.26%151.51%20.55%122.58%0.41%-
EPS (Basic)
-0.49-2.29-3.74-16.82-43.36-49.80-55.60-22.00
EPS (Diluted)
-0.49-2.29-3.74-16.82-43.36-49.80-55.60-22.00
Free Cash Flow Per Share
-0.59-2.84-3.66-16.22-37.66-43.08-47.16-18.10
Gross Margin
23.66%----100.00%96.50%100.00%
Operating Margin
-14624.11%-----8424.28%-440.82%-187.51%
Profit Margin
-14896.88%-----9082.11%-497.76%-131.95%
Free Cash Flow Margin
-17948.66%-----7855.27%-422.61%-108.73%
EBITDA
-31.22-36.38-34.22-25.74-26.1-24.41-9.35-4.42
EBITDA Margin
-13939.29%-----7799.04%-326.84%-104.00%
EBIT
-32.65-37.07-34.98-28.29-28.64-26.86-12.39-4.85
EBIT Margin
-14575.89%-----8582.43%-433.17%-114.07%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).